Abstract
Allogeneic islet cell transplantation is currently the only curative treatment of diabetes mellitus. However due to organ shortage islet transplantation is limited and immunsupressive protocols are hazardous and complicated side effects. The incidence of diabetes is constantly growing and a treatment with autologous insulin producing cells would hold great promise for the therapy of diabetes. We herein describe the generation of insulin producing »Neo-islet cells« from human peripheral blood monocytes, which are able to secret insulin in a glucose dependent fashion and normalize blood glucose levels after transplantation into diabetic mice for a period of ten days. In comparison with pancreatic islet cells »Neo-islet cells« exhibit a gene expression pattern which is comparable to an endocrine precursor cell as known from embryonic pancreas developmental studies.
Human monocytes were treated with MCSF and IL-3 in order to undergo a step of dedifferentiation. Further culture in EGF, HGF and nicotinamide for 4 to 8 days resulted in the formation of cell aggregates expressing insulin, somatostatin and glucagon. Insulin and C-peptide secretion was shown to be glucose dependent after incubation with 22mM glucose whereas 3mM glucose did not induce insulin secretion. MRNA was isolated from »Neo-islet cells« at different times and analyzed for expression of insulin, somatostatin, glucagon, PDX-1, Ngn3, carboxypeptidase, Nkx6.1, NeuroD, Glut2, Ngn3, MAFa and Pax4. Stable expression of insulin, carboxypeptidase, glucagon, Maffa, Nkn6.1, Ngn3 and Neuro D was found. The expression of somatostatin, Isl-1, pro-hormone-convertase, Glut2, Pax 4 and PDX 1 was not reproducible in all experiments and so far not stable. Although »Neoislet cells« are not fully differentiated they were able to normalize blood glucose in diabetic mice transiently. We hope to characterize these cells in more detail in order to optimize the differentiation protocol as a perspective for autologous cell therapy of diabetes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Soria B (2001) In-vitro differentiation of pancreatic β-cells. Differentiation 68:205–219
Jansen J (2004) Gene regulatory factors in pancreatic development. Developmental Dynamics 229:176–200
Matsuoka M, Artner I, Henderson E, Means A, Sander M, Stein R (2004) The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. PNAS 101:2930–2933
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this paper
Cite this paper
Ruhnke, M. et al. (2005). Generierung von insulinproduzierenden »Neo-Inselzellen« aus humanen Monozyten — Analyse des Differenzierungsstatus. In: Rothmund, M., Jauch, KW., Bauer, H. (eds) Chirurgisches Forum 2005. Deutsche Gesellschaft für Chirurgie, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26560-0_5
Download citation
DOI: https://doi.org/10.1007/3-540-26560-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-24888-0
Online ISBN: 978-3-540-26560-3
eBook Packages: Medicine (German Language)